分組召集人：
生醫組：莊德茂院士 (De-Maw Chuang, Ph.D.)
能源組：許翼雲博士 (Yi-Yun Hsu, Ph.D.)
經濟組：李五郎博士 (Wu-Lang Lee, Ph.D.)
The Chinese-American Professionals Association
of Metropolitan Washington, D.C., USA (CAPA)
P.O. Box 1501
Rockville, MD 20849
E-Mail: capa.dc@gmail.com
Website: http://www.capadc.org
2009 年度華府國建聯誼會
幹事會 Executive Committee
顧
問 Advisors
會 長：陳明珠 Joanna Lin
林正英 Jeng-Eng Lin
副會長：張文進 James Chang
吳東麟 Thomas Wu
會 籍：葉淑美 Grace Wei
鄧德成 Apollo Teng
企 劃：涂曼麗 Julia Liu
郭麗美 Li-Mei Kuo
財 務：黃秉驥 Bing-Jib Huang
秘 書：張景杰 George Chang
公 關：黃瑞禮 Ray Hwang
Non-profit Tax-exempt Organization Tax ID: 52-1385138
議程手冊編輯：黃瑞禮
華府國建聯誼會 2009 年學術研討會
CAPA 2009 Annual Symposium
新挑戰、新展望
New Challenge · New Outlook
Program 議程
8:30-9:00
Registration and Coffee/Tea -- 報到註冊
9:00-9:05
CAPA President’s Welcoming Remarks
會長致歡迎詞
9:05-9:15
TECRO Representative’s Remarks
中華民國駐美代表致詞
9:15-9:20
Conference Chair’s Opening Remarks
總召集人致開幕詞
De-Maw Chuang
莊德茂
9:20-10:10
Keynote Speech: “Scientific and Social
Perspectives from an Asian Virologist”
專題演講:
「一位亞裔病毒學家的科學觀與社會觀」
Kuan-Teh Jeang
蔣觀德
10:10-10:20
Break -- 休息
10:20-12:00
Forum on Biomedical Science:
Recent Advances
生醫組: 生物醫學最新的發展
“Challenge of Curing Cancer with a New Approach”
「治癌的新看法及策劃」
“Potential of Stem Cell Therapy in Neurological
Diseases”
「使用幹細胞療法治療神經疾病的可行性」
“Nanomedicine: A Giant Leap for Medicine”
「奈米醫學：醫學上的大躍進」
12:00-12:50
Lunch -- 午餐
12:50-2:20
Forum on Energy:
The Two Sources That Can Slow Down Global
Warming
能源組: 緩和地球暖化的兩種能源
“Conversion of Cellulosic Waste into Fuels and
2
Joanna Lin
陳明珠
Jason Yuan
袁健生
Chair:
De-Maw Chuang
召集人：莊德茂
Ru-Chih Huang
黃周汝吉
Li-Kai Tsai
蔡力凱
Kuan Wang
王寬
Chair:
Yih-yun Hsu
召集人: 許翼雲
Chemicals”
「廢棄物轉化能源」
George T. Tsao
曹祖寧
“Overview of Nuclear Power Plant Operations”
「核能發電概觀」
2:20-2:30
Pao-Tsin Kuo
郭寶金
Break -- 休息
2:30-4:45
Forum on E Forum on Economics:
Trading Arrangements, Investment, and State of
the Economy in the U.S. and Taiwan
經濟組: 貿易協定、投資、及美台經濟現況
“The Economic Costs and Benefits of Investing in
China by Taiwan’s Companies”
「台商在中國投資的經濟成本與效益」
Chair:
Wu-Lang Lee
召集人: 李五郎
Charles Ou
歐昭惠
“ECFA – Regional and Global Perspectives”
「從區域性與全球性的角度看台、中經濟合作架構
協議」
Peter CY Chow
周鉅原
“State of the U.S. and Taiwan Economies: Some
Cyclical Perspectives”
「從景氣循環角度看台、美經濟現況」
Yin-Kann Wen
and Wu-Lang Lee
4:45-4:55
Summary and Concluding Remarks
結語
De-Maw Chuang
莊德茂
4:55-5:00
Closing Remarks
閉幕語
溫英幹與李五郎
Julia Liu
涂曼麗
3
Keynote Speech:
Scientific and Social Perspectives from an Asian Virologist
一位亞裔病毒學家的科學觀與社會觀
Kuan-Teh Jeang, M.D. Ph.D.
Abstract
As we move into the 21st century, some things are changing while others remain the same.
Unlike the 20th century, the 21st century is referred to by many as the “Pacific century”,
suggesting that the epicenter of economics, science, and social advances is shifting towards
the Pacific rim countries. Thus, for Asians this is a time of great responsibility and
opportunities. In this context, from the vantage point of an Asian American virologist, born in
Asia but educated since childhood in the US, what are the important scientific and social
topics worthy of discussion?. First, an unchanging topic of significant pandemic importance
remains the scourge of HIV-1/AIDS which will likely accelerate in Asia in the coming years.
Second, Asian scientists in America are increasingly significant in number and productivity,
and will face important leadership choices and challenges. Dr. Jeang will his offer personal
reflections on both subjects.
Kuan-Teh Jeang, M.D. Ph.D. (蔣觀德院士)
Dr. eang received his M.D. and Ph.D. degrees from the Johns
Hopkins University School of Medicine (Baltimore, USA). Since
1985, Dr. Jeang has been at the National Institutes of Health
(Bethesda, USA). He is currently the Head of the Molecular
Virology Section in the Laboratory of Molecular Microbiology,
NIAID. Dr. Jeang has published over 250 peer-reviewed articles,
cited over 11,500 times, and has an H-index of 59. His research
interests focus on the gene regulation of HIV and how HTLV-1
causes leukemia. He is the President-Elect of the Society of
Chinese Bioscientists in America (SCBA), a three-term editorial
board member of the JBC, the Editor-in-Chief of Retrovirology,
an Academician of Academia Sinica, and an elected Fellow of
the AAAS, the ASCI, and the AAP. Dr. Jeang was a recent past Councilor of the ASBMB. He
is the 2009 recipient of the Woodrow Wilson Award for Distinguished Government Service
from the Johns Hopkins University Alumni Association.
4
Forum on Biomedical Science:
Recent Advances
生醫組: 生物醫學最新的發展
Chaired by De-Maw Chuang
Speakers: Ru-Chih Huang, Li-Kai Tsai and Kuan Wang
Abstract
In recent years, there has been remarkable progress in research in the biomedical sciences.
Genetic loci and disease-causing genes have been identified for a vast number of illnesses.
Disease pathophysiology and pathogenesis are now globally better understood. Much
improved techniques have been developed for preclinical experimentation, drug development,
disease diagnosis and treatment. Nanotechnology has proven to be an invaluable tool for
drug delivery, drug discovery, disease diagnosis and regenerative medicine. Stem cell
transplantation has been shown to have strong beneficial effects in multiple animal models
and some clinical settings of neurodegenerative diseases, raising the hope that this could be
“a fountain of youth”. Novel drugs and new treatments have been developed and some are
already in clinical trials for hard-to-treat diseases such as terameprocol for cancer. In this
session, three outstanding researchers, Drs. Ru-Chih Huang from Johns Hopkins University,
Li-Kai Tsai from National Taiwan University Hospital and Kuan Wang from the National
Institutes of Health, will address the new opportunities and new challenges in these important
areas of biomedical research.
De-Maw Chuang, Ph.D. (莊德茂院士)
Dr. De-Maw Chuang received his B.S. degree from National
Taiwan University and Ph.D. degree from the State University
of New York at Stony Brook. He is currently the Chief of the
Molecular Neurobiology Section at the National Institute of
Mental Health, National Institutes of Health in Bethesda, MD.
He is considered to be a world expert in the area of
neurobiology of mood stabilizers, and has published over 230
papers in peer-reviewed journals and books. He has received
many honors and awards, including the NIH Director’s Award
in 1997 in recognition of “his superb leadership and innovative
research which advances the understanding of basic
mechanisms
involved
in
neurodegenerative
and
neuropsychiatric disorders”. He is also the recipient of the 2002 NARSAD Distinguished
Investigator Award. He was inducted to the Academia Sinica in Taiwan in 2006. He served
as the past President of CAPA and the Society of Chinese Neuroscientists in America as well
as the Secretary of the Society of Chinese Biologists in America. Currently, he is a member
of the advisory board of the Institute of Biomedical Science, Academia Sinica, and the Mental
Health/Neuroscience Division of the National Research Health Institute in Taiwan.
5
Challenge of Curing Cancer with a New Approach
治癌的新看法及策劃
Ru-Chih Huang, Ph. D.
報告摘要
癌細胞是起源於人體之正常細胞。在繁殖過程中，癌細胞不斷地發生基因變異，而發展至腫瘤
階段時，癌細胞群內的各個細胞已發展出不同的細胞型態，因此，對於藥物的反應也不盡相
同，甚至有部分的細胞已不受藥物之控制，仍持續進行快速分裂。目前，發展治癌藥之瓶頸在
於癌細胞有極強的抗藥性，為了控制生長極為快速的癌細胞，往往須增大藥量，故無法避免對
正常細胞的傷害。黃教授實驗室自 1990 年代首次發表抗病毒、抗癌新藥 TERAMEPROCOL (M4N)
之學術論文。M4N 之抗癌原理並非以生長蛋白為標靶，而是改以防止基因轉錄的方式來降低癌
細胞過量蛋白的含量。M4N 源自藥用植物，並有數千年之使用歷史，在抑制癌細胞快速繁殖的
同時，也不會傷害正常細胞。ERIMOS 公司已完成多種抗癌治療之第一/二期之臨床試驗，證明
其具有穩定的抗癌效果。在單藥使用上，M4N 在口腔癌、子宮頸癌、卵巢癌及血癌之療效顯
著。根據最新臨床前研究成果顯示，將 M4N 與 ETOPOSIDE 或 RAPAMYCIN 合用，可對數種腫瘤
具有抑制癌細胞生長及擴散之效果，目前人體抗癌的臨床實驗尚待進行中。
Ru-Chih Huang, Ph.D. (黃周汝吉 院士)
黃周汝吉女士於 1953 年畢業於國立台灣大學，並通過考試院高等
考試。而在 1960 年獲得俄亥俄州立大學生物化學博士學位後，即
進入加州理工學院擔任研究員一職，共歷時五年。而後，黃周汝
吉女士獲聘為約翰霍普金斯大學生物系教授，並任教至今。黃教
授之研究著重在染色體結構與基因表現，研究成果豐碩並擁有多
項專利、著作，其受聘為美國國家衛生院諮詢委員前後十五餘
年。1980 年代，黃教授曾應國家的邀請，回國短期服務，期間黃
教授會同國內外之相關學者，創立了中央研究院分子生物研究
所，造就了許多日後發展國家生物基礎科學之棟樑。1982 年，黃
周汝吉女士當選中央研究院院士，且於同年獲頒美國傑出科學家
獎。1985 年更獲收錄為美國十大女科學家傳記名錄。基於黃教授
在其領域的卓越貢獻，2001 年獲約翰霍普金斯大學 Legacy of
Science 之殊榮。近年來，黃教授的研究重心為藉由化學分子的作用以改變基因啟動子於染色體
上的結構，進而達到抑制愛滋病毒與癌細胞繁殖的目的。
6
Potential of Stem Cell Therapy in Neurological Diseases
使用幹細胞療法治療神經疾病的可行性
Li-Kai Tsai, M.D.
Abstract
Stem cells feature high proliferation, differentiation, and migratory capacity, which contribute
to their beneficial effects in animal models of neurological diseases. Currently, stem cells can
be obtained not only from embryos, but also naturally from adult tissues. They can even be
generated artificially from mature cells such as human skin fibroblasts. In neurodegenerative
disorders, neurons die continuously with progressive neurological deficits. Stem cells
transplanted into affected brain or spinal cord regions have the potential to replace
degenerated neurons and restore normal function in a variety of neurological disorders
including Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and spinal
cord injury. Moreover, certain stem cells have the ability to migrate toward an injured brain
site and release neuroprotective and anti-inflammatory substances to combat neuronal death.
Some stem cells, when injected into the blood stream, can even find their way to the injured
brain and enhance functional recovery such as in cases of stroke and multiple sclerosis.
Although there are still many obstacles such as safety issues to be overcome before clinical
application, stem cells, like a fountain of youth, have a great potential to join into current
medicine and bring hope for the future cure of neurological diseases.
Li-Kai Tsai, M.D. (蔡力凱醫師)
Dr. Li-Kai Tsai was born in Tainan, Taiwan. He graduated from
National Taiwan University with an MD degree in 1999, and
was trained as a neurologist at the National Taiwan University
Hospital (NTUH). After receiving his license in neurology in
2003, he also did a training at the Department of Medical
Genetics in NTUH. Currently, he is an attending staff member
at the Department of Neurology, NTUH, and is taking a leave
to conduct stem cell research at the National Institute of Mental
Health, National Institutes of Health in Bethesda, MD. His
research interests are in the areas of cerebrovascular and
motor neuron diseases. In the last three years, he has had
more than ten publications in clinical neurology and
neuroscience, and has been invited to a number of
international symposia. He was considered as one of the
“Recommended Best Doctors” in Taiwan by Business Weekly
in 2008. He was also granted the Best Publication Award by the Taiwan Stroke Society in
2005, and awarded an honorary membership to the Phi Tau Phi Scholastic Honor Society in
2008.
7
Nanomedicine: One Giant Leap for Medicine
奈米醫學：醫學上的大躍進
Kuan Wang, Ph.D.
Abstract
Nanomedicine is an emerging discipline that applies nanotechnology to medicine. It involves
the design and fabrication of tiny bio-compatible materials and devices at the length of
nanometers. Non-medical applications of nanotechnology are now well entrenched in the
fields of energy, optics and computing devices. One major challenge in innovative medical
applications is how to make the material/devices small, full-featured and “body-friendly”.
Another key element of success is the requirement for a highly interdisciplinary scientific
team including biologists, physicians, mathematicians, engineers and computer scientists that
share the same vision, passion and a common language.
In this brief talk, recent advances in drug delivery, drug discovery, diagnostics, in vivo
imaging, stem-cell and regenerative medicine and toxicology as well as team-building will be
highlighted.
Kuan Wang, Ph.D. (王寬院士)
Dr. Kuan Wang is currently the Lab Chief of the Laboratory of
Muscle Biology and Section Head of the Muscle Proteomics
and Nanotechnology Section at the National Institute of Arthritis
and Musculoskeletal and Skin Diseases, National Institutes of
Health. Dr. Wang was elected as an Academician of Academia
Sinica in 2006. He serves as a member of the NIH
Nanomedicine Roadmap Implementation Team.
Dr. Wang received his B.S. degree from National Taiwan
University in chemistry, and Ph.D. degree from Yale
University in biochemistry and biophysics. His research team investigates muscle proteome,
muscle physiology, mechanical biology and cell motility, including the discovery and naming
of five new cytoskeletal proteins [filamin, titin, nebulin, P235 (talin) and nebulette] which are
important in assembly, regulation and dysfunction of the cytomatrix and motility in cardiac,
skeletal and smooth muscles and in non-muscle cells. He is directing an interdisciplinary
team of biologists, chemists, engineers, and physicists to advance nanobiotechnology,
including the design of a nanomechanical device for single molecules and single cells, protein
engineering, drug design and bio-informatics, to address the coupling of elasticity and
interaction of intrinsically disordered signaling proteins, the mechanical stress sensing and
transduction in cellular signaling and the molecular mechanisms of heart and skeletal muscle
diseases and their treatments.
8
Forum on Energy:
The Two Sources That Can Slow Down Global Warming
能源組：緩和地球暖化的兩種能源
Chaired by Yih-yun Hsu
Speakers: P.T. Kuo and George T. Tsao
Abstract
Today, one big concern is global warming, and finding alternative fuels with low/no
generation of carbon dioxide in air. Among the candidates mentioned are solar energy, wind
energy, and nuclear energy, all of which are carbon-free; and bio-fuels which gives no net
generation of carbon dioxides. However, solar and wind energy are not practical due to their
unreliability, low efficiency. Thus, the only viable carbon- free energy source is nuclear. As to
the bio fuel, popular source is to convert starch, such as corn, into alcohol. But this approach
is to competing against food need. The alternative is fuels from bio-waste, such as corn stalk.
It utilizes waste material, and also helps environment.
In this session, we have two reports on these viable alternatives: the nuclear energy and
bio-waste fuel, including the technology and economical aspects of such two sources.
Yih-yun Hsu, Ph.D. (許翼雲博士)
B.SC., Che.E., Taiwan University
Ph.D., Che. Eng., University of Illinois (1958)
Senior research engineer, NASA and AEC/NRC; Professor of
Chem Eng. and Nuc. Eng., Univ. of Maryland; Chairman of
AEC-ROC; Visiting Chair Professor, Taiwan Univ. and Tsinghua
Univ. He retired in 1997 as Prof. Emeritus of UMCP.
Hsu had written a book on boiling heat transfer, which had been
used as graduate course text book in several universities. He
received several major awards from ASME, AIChE, ANS, and
CNS. He was elected as fellow of AIChE and ANS, and also the
Member of International Nuclear Energy Academy.
In non-technical area, Hsu was the co-founder of Chinese American Society; Washington
China Post, and Gaithersburg Chinese School. He also served as President of CAPA.
9
Overview of Nuclear Power Plant Operations
核能發電概觀
P. T. Kuo, Ph.D.
Abstract
This presentation will provide an overview of nuclear power plant operation in the past and a
summary of the general trend of current operating nuclear plant. It will discuss some of the
major issues experienced in the US and the corrective actions taken to alleviate concerns
about nuclear safety. It will also take a closer look at what the international community has
done to maintain plant safety towards extension of the life of current operating nuclear plants.
It will also attempt to provide an update of current activities on planned construction of new
nuclear power plants. The focus will be primarily on those activities in US, China and Taiwan.
P.T. Kuo, Ph.D. (郭寶金博士)
GP.T. Kuo recently retired from the Nuclear Regulatory
Commission after 32 years of Federal service. Prior to his
retirement, he served as the Director of Division of License
Renewal in the Office of Nuclear Reactor Regulation. He also
served in the nuclear industry before he joined the NRC for 6
years.
P.T. Kuo held a Ph.D. degree from the Rice University. He
was one of the recipients of the top 10 Federal Engineers in
1992. He was also granted the Presidential Ranking Award in
2008.
10
Conversion of Cellulosic Waste into Fuels and Chemicals
廢棄物轉化能源
George T. Tsao, Ph.D.
Abstract
This talk will concentrate on recent development of cellulosic ethanol and butanol from rew
renewable resource materials. A process design will be presented that involves conversion of
cellulose fraction in materials like wood and cornstalks into ethanol and the hemicellulose
fraction into chemicals and also butanol. Unlike most of publicly announced projects going
on all over the world that concentrate on conversion of cellulose, this process design converts
all available carbohydrates into value added products and should have the best chance of
success. The next phase of the work will involve pilot plant tests and construction of a
demonstration plant.
George T. Tsao, Ph.D. (曹祖寧博士)
George T. Tsao (Tsao Tsu Ning) was born in
Nanjing. He graduated from Tai-Da (Taiwan University) in 1953
with BS in Chemical Engineering. After receiving Ph.D. in 1960
also in Chemical Engineering from University of Michigan, he
worked for six years in bio-industry and then joined faculty of
Iowa State University. In 1974, he moved to Purdue University.
His field of interests has been biochemical engineering and
renewable resources technology. He established a Laboratory
of Renewable Resources Engineering at Purdue. After research
and teaching for 30 plus years, he retired fully from Purdue in
2006. He has published over 300 technical papers, trained 72
PhD and 64 postdoc students.
11
On the Costs and Benefits of Taiwan’s Investment in People’s
Republic of China
台商在中國投資的經濟成本與效益
Charles Ou, Ph.D.
Abstract
This presentation will develop an economic argument that foreign investment by Taiwan’s
corporations to a developing country, such as PRC and others, contribute little to the longterm economic growth of Taiwan. The basic propositions are as follows:



The macro-economics of a country’s growth is dictated by the growth of private
business investments at home—private investment as one of the exogenous variables
that can be “managed or manipulated” by government actions. Business investments
in Taiwan are the only path to maintain growth and increase productivity (through
expansion in production capacity and R&D ventures) and thus higher living standard
and economic prosperity.
Business investments abroad, say in PRC, by Taiwan’s companies will only helps the
international competitiveness of these companies, but not Taiwan’s economy-- the socalled fallacy of composition, i.e. what is good for a company’s investment in foreign
markets by increasing the company’s earnings and growth may not necessary be good
for the growth of income and output of the host nation (Taiwan).
It is investment in advanced industrialized nations that offers greater growth potentials
through technology transfer to Taiwan, R&D joint ventures, and foreign direct
investments from these countries to Taiwan.
Charles F. Ou, Ph.D. (歐昭惠博士)
Dr. Ou is a senior economist with the U.S. Small Business
Administration's Office of Economic Research and has been with
Advocacy since 1977. He earned a B.A. degree in economics from
NTU and a Ph.D. in economics from the University of North Carolina
at Chapel Hill. He taught economics at Wake Forest University, the
University of Dayton, Ohio, and Queens College of Charlotte, N.C.,
where he served as an Associate Professor and the department chair
for 1977-78. With specialties in capital and credit markets, the
financial aspects of small business issues, and economic
development in the U.S.A., Dr. Ou has done an extensive work on
small business capital access issues, including development of
databases for financial research. His papers appeared in the Journal
of Finance, Journal of Small Business Economics, and Journal of
Entrepreneurial Finances; he is the principal writer of the financing
chapter of the State of Small Business report(s) and the Small
Business Economy, and reports published by the Office of Advocacy.
He currently serves on the editorial board of two professional small business journals.
12
ECFA in Regional and Global Perspectives
從區域性與全球性的角度看台、中經濟合作架構協議
Peter C.Y. Chow, Ph.D.
Abstract
The proliferation of regional trading arrangements in East Asia has generated “spaghetti
bowl” with Taiwan as an outlier due to the “China” factor. Taiwan needs to breakthrough the
tendency of being marginalized. Its ultimate choices are vital to U.S. economic and security
interests in East Asia. While a U.S.-Taiwan free trade agreement would prove mutually
beneficial to both countries, an Economic Cooperation Framework Agreement (“ECFA”) with
China would have serious socio-economic and political consequences for Taiwan’s future.
Merely signing an ECFA with China will not prevent the marginalization of Taiwan, nor will it
enable Taiwan to further integrate itself into the East Asian or global economic community.
Deepening engagement with China without simultaneously strengthening its economic ties
with other industrialized countries would make Taiwan vulnerable to systemic risk. Moreover,
Beijing may also gain greater political leverage over Taiwan, which would definitely erode
Taiwan’s “de facto” autonomy. Without falling into the trap of Krugman’s “hub-spoke” model,
Taiwan would need to simultaneously sign multiple free trade agreements with many of its
trading partners.
Peter C.Y. Chow, Ph.D. (周鉅原博士)
Dr. Chow is a Professor of Economics at the City College & Graduate
Center, City University of New York since 1986. He was a Visiting
Research Fellow at the Hoover Institution (1983), Stanford University,
and the University of California at Berkeley (1975-76), and a Visiting
Professor at the National Taiwan University in Taiwan as well as at
Nagoya National University in Japan. He was also a Research Associate
at the National Bureau of Economic Research and a contractual
consultant for the World Bank. His main interest is in international trade
and economic development, with focus in late industrialization in East
Asia.
In addition to more than 40 articles published in professional journals, he
has published eight books: “The Growth and Stability of A Small Open
Economy,” “China's Modernization in Relation to the U.S.,” (Both by the
Alpha Edition, Burgess Publishing Company), “Trade - The Engine of Growth in East Asia,”
(Oxford University Press, co-authored with Mitchell Kellman), “Weathering the Storms: Taiwan, Its
Neighbors and Asian Financial Crisis,” (Co-edited with Bates Gills, The Brookings Press),
“China’s Economy after Deng: A Long Term Perspective,” (Contemporary Asian Studies 1995,
No.5. Univ. of Maryland School of Law), “Taiwan in the Global Economy,” (Edited with an
introduction. Prager, 2002), “Taiwan’s Modernization in Global Perspective,” (Edited with an
introduction. Prager. 2003), “Economic Integration, Democracy and National Security in East
Asia,” (Edited with an introductory chapter. Edward Elgar, 2007), and “The ‘One China’ Dilemma,”
(Edited with an introductory chapter, Palgrave Macmillan, 2008).
13
State of the Taiwan Economy: Some Cyclical Perspectives
金融危機的衝擊、臺灣的因應措施及經濟景氣展望
Yinkann Wen, Ph.D.
Abstract
This session will discuss the impact of this once-in-century’s financial tsunami, analyze
Taiwan’s responses in restoring her economy by various financial and fiscal policies, and
offer some views on the prospects of Taiwan’s future economic development.
摘要
面對百年一見的金融海嘯，世界各國都致力利用財政與貨幣政策試圖搶救企業及降低失業率，
使景氣恢復。本節先簡單探討金融危機之起因和衝擊，解析臺灣在對抗金融危機中所採取的各
種政策措施及成效，並提出對其未來經濟發展之展望的一些看法。
Yinkann Wen, Ph.D., CFA (溫英幹博士)
Dr. Wen, Chartered Financial Analyst, is a Professor Emeritus at
the National Dong Hwa University, Hualian, Taiwan, and a
member of the Board of the Directors of the Central Bank of ROC
in Taipei. A graduate of NTU (B.A. and M.A. in Economics) and
Johns Hopkins (Ph.D. in Political Economy), Dr. Wen, served in
the World Bank as a Senior Economist, prior to his return to
Taiwan in 1996.
國立台灣大學經濟系學士及及經濟研究所碩士，美國約翰霍普金斯
大學政治經濟博士。擁有美國特許財金分析師（CFA）及中華民國
證券分析師資格。在世界銀行(World Bank)擔任經濟專家，服務二
十幾年後退休（1974 -1998），之間曾在世銀經濟發展學院任教及
年金管理局擔任資深經濟專家。2003-2004 自國立東華大學休假期
間曾擔任世界銀行訪問學者。1996 年起在台灣花蓮之國立東華大
學任教，曾任該校大陸研究所所長，經濟系主任兼國際經濟研究所所長。現為東華大學榮譽教
授，並於 2005 年一月開始擔任中華民國中央銀行第十七屆理事。
14
State of U.S. Economy: Some Cyclical Perspectives*
美國經濟景氣展望
Wu-Lang Lee, Ph.D.
Abstract
The presentation will focus on the state of U.S. economy from a cyclical perspective. The
topics covered include a review of current state of the economy, major factors underlying the
current downturn, duration of postwar cyclical downturns, similarities and differences between
the current recession and the Great Depression of 1930s, major indicators used to track the
trend of the economy, counter cyclical measures U.S. administration has implemented, and
lessons learned from the prior recessions in the U.S. and abroad. Some highlights of
selected forecasts by government analysts and private forecasters, possible shape of
economic recovery, and major risk factors underlying the forecasts will also be presented.
*The views expressed here are those of the speaker only. They do not represent those of
IRS or U.S. Department of the Treasury.
Wu-Lang Lee, Ph.D. (李五郎博士)
Wu-Lang is a Senior Economist and a Manager at the
Headquarters Research Division, Internal Revenue Service,
U.S. Department of the Treasury. His current research interests
include taxpayer compliance burdens, taxpayer services,
indexing of tax codes, and U.S. business cycles. Prior to joining
government services, Wu-Lang was a Research Associate and
Project Director at National Bureau of Economic Research
(NBER). His research at NBER included the development of a
macro-econometric multi-regional policy simulation model for
the Department of Commerce to assess the economic impact of
development programs on the less developed regions of the
United States. Wu-Lang later joined GM’s N.Y. Headquarters
as an economist, advising its Board of Directors, Finance
Committee, Administration Committee, and GM Pension
Investment Corporation on a variety of economic and strategic matters. Since joining the IRS,
Wu-Lang served as an Industry Economist in Corporate Examination, a Senior Economist in
Enforcement Revenue, a Lead Economist, Acting Chief, and Project Manager in the
Research, Analysis and Statistics Division. His expertise includes econometric modeling,
economic forecast, business cycle studies, transfer pricing, industry organization, and tax
administration. Wu-Lang earned his B.A. from NTU, and M.A. and Ph.D. from the University
of Rochester, New York.
15